The importance of CREBBP and EP300 mutation is underscored following analysis of tumor tissues in several cohorts of patients with SCC of the head and neck, lung, or cervix treated with radiation therapy, identifying these mutations as associated with radioresistance and poor outcome. Here, CREBBP is linked to neoplasm.